Physicians' Academy for Cardiovascular Education

Challenges in ASCVD reduction and TG-related risk

10' education - Sep. 20, 2023 - Erik Stroes, MD, PhD - Amsterdam, The Netherlands

Video navigation menu

  • Residual risk 0:14
  • Triglyceride-rich lipoproteins and atherogenesis 1:13
  • Intervention trials 4:58
  • New agents 6:42


Show transcript

Educational information

This lecture by Erik Stroes was part of the EBAC-accredited symposium "Improving the management of patients with atherosclerotic cardiovascular disease - The evolving role of icosapent ethyl" at the ESC congress 2023.


Prof. Erik Stroes, MD, PhD is professor of Vascular Medicine at Amsterdam University Medical Center in Amsterdam, The Netherlands.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Amarin.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: